HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtech Denorex “Deep Down Dandruff Relief” Ads Debuting In November

This article was originally published in The Rose Sheet

Executive Summary

Medtech Products will launch a multi-million dollar ad campaign in November to reacquaint dandruff sufferers with Denorex medicated shampoos and conditioners

You may also be interested in...



In Brief: Whitehall-Robins

Whitehall-Robins: Selling 10 "niche" healthcare brands to H&BA marketer Medtech, the American Home Products consumer healthcare subsidiary announced Sept. 10. The brands being sold are Zincon medicated shampoo, Compound W wart remover, Oxipor psoriasis treatment, Arthritis Pain Formula, Momentum muscle pain medication, Freezone corn and callus remover, Outgro toenail medication, Heet liniment, Dermoplast antiseptic spray and Sleepeze sleep aid. The brands represent about $25 mil. in gross sales for Whitehall-Robbins. The purchase, which fits in with Medtech's current H&BA offerings (Nudit hair remover) will double the firm's size...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
UsernamePublicRestriction

Register

RS010707

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel